MedTrace Logo

Intensive Care - GLObal Study on Severe Acute Respiratory Infection

NCT01936207 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 800

Last updated 2014-12-11

No results posted yet for this study

Summary

IC-GLOSSARI (The Intensive Care GLObal Study on Severe Acute Respiratory Infection) is a multicentre, prospective, observational,14-day inception cohort study designed and conducted by the ESICM Trials Group to investigate the epidemiology and microbiology profiles of ICU-SARI, document commonly used treatment and monitoring strategies, measure current outcomes and identify potential topics for multidisciplinary studies ranging from interventional clinical trials to fundamental mechanisms of disease.

The purpose of this study is to answer the following questions:

What is the frequency and disease burden of SARI for ICU's worldwide? What are the aetiologies of ICU SARI? How are SARI patients diagnosed and managed in the ICU? What is the outcome from SARI in the ICU? Is there a difference in outcomes from SARI depending on the aetiology of the disease? Can we identify high-risk categories of SARI that could constitute a defined population for an interventional study?

Conditions

  • Severe Acute Respiratory Failure

Sponsors & Collaborators

  • European Society of Intensive Care Medicine

    lead OTHER

Principal Investigators

  • Yasser SAKR · University Hospital JENA

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-11-30
Primary Completion
2014-11-30
Completion
2014-11-30

Countries

  • Belgium

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01936207 on ClinicalTrials.gov